How Supplied:
15% ointment, 15 g
Indications and Usage:
Veregen is indicated for the treatment of external genital and perianal warts (Condylomata acuminata) in immunocompetent patients 18 years and older.
Prescribing Instructions:
Prescribing Information Instructions [PDF]
Side Effects and Contraindications:
Veregen has not been evaluated to treat urethral, intra-vaginal, cervical, rectal, or intra-anal human papilloma viral disease and should not be used to treat these conditions. Avoid use of Veregen on open wounds. Avoid exposure of Veregen-treated areas to sun/UV-light because Veregen has not been tested under these circumstances. Safety and efficacy of Veregen have not been established in immunosuppressed or pediatric patients, or pregnant women, or for the treatment of external genital and perianal warts beyond 16 weeks or for multiple treatment courses. The most common adverse reations are local skin and application site reactions include (incidence >20%) erythema, pruritus, burning, pain/ discomfort, erosion/ulceration, edema, induration, and rash vesicular.
Company:
PharmaDerm, a division of Nycomed US
866-337-6457
veregen.com
MyList
Drugs
